Top Story

Califf named FDA deputy commissioner for medical products and tobacco

January 27, 2015

The FDA announced that Robert Califf, MD, a leader in CV medicine, clinical research and medical economics, has been appointed as deputy commissioner for medical products and tobacco.

Califf will oversee the FDA’s Center for Drug Evaluation and Research, the Center for Biologics Evaluation and Research, the Center for Devices and Radiological Health, the Center for Tobacco Products and the Office of Special Medical Programs. He will provide advice and policy direction on the FDA’s medical and tobacco priorities and will manage initiatives in areas such as personalized medicine, orphan drugs, pediatric science and the advisory committee system, according to a press release.

In the Journals

DAYLIGHT: Vitamin D supplementation did not lower BP

January 27, 2015
In vitamin D-deficient patients with prehypertension or stage 1 hypertension, vitamin D supplementation did not decrease BP levels.“A large body of epidemiological…
Abe Morgentaler In the Journals

Testosterone therapy could benefit CV health, contrary to several studies

January 27, 2015
No convincing evidence exists to link increased cardiovascular risks with testosterone therapy, according to a review published in Mayo Clinic Proceedings.Rather…
In the Journals

Transradial access may be preferable for patients with stable ACS

January 26, 2015
Compared with transfemoral access, transradial access was associated with reduced bleeding, fewer access-site complications and improved outcomes in a large cohort of…
Michael Weber In the Journals

Isolated systolic hypertension conferred higher mortality risk in young adults

January 26, 2015
Isolated systolic hypertension during young and middle age was associated with increased long-term risk for death related to CVD and CHD compared with optimal…
More News Headlines »
CME
Obesity Consults: Volume 2, Number 1

Obesity Consults: Volume 2, Number 1

This activity is supported by an educational grant from Vivus, Inc.

Obesity is suboptimally managed in clinical practice despite the availability of relevantguidelines and evidence-based…
More »
Meeting News Coverage Video
thumbnail for video 3945938325001

Kirk N. Garratt, MD: Prolonged DAPT beneficial in patients with paclitaxel-eluting stents

December 16, 2014
CHICAGO — In this video, Kirk N. Garratt, MD, of the Lennox Hill Hospital, New York, outlines results of a study…
More »
CME
Individualizing T2DM Treatment: Determining Optimal Pathways That Lead to Achieving Target Goals

Individualizing T2DM Treatment: Determining Optimal Pathways That Lead to Achieving Target Goals

This activity is supported by educational grants from Lilly USA, LLC and Novo Nordisk.

The prevalence of type 2 diabetes mellitus has escalated in recent years and targeting treatmentcontinues to be a…
More »
morganatic-roan